BioCentury
ARTICLE | Clinical News

I-vation Implant: Suspended Phase IIb enrollment

August 18, 2008 7:00 AM UTC

SurModics said partner Merck suspended enrollment of a Phase IIb trial of I-vation triamcinolone acetonide (TA) in patients with diabetic macular edema (DME). SurModics said Merck is reevaluating the ...